Leading Pharmaceutical Wholesalers and Distributors in Poland
Published On : October 2026
Why the Polish Wholesaler List Overlaps
The companies covered in the report are Grupa Olmed, NEUCA Group, Pelion S.A., Farmacol S.A., PGF Polska Grupa Farmaceutyczna, ACP Pharma, Salus International, Prosper S.A., Cefarm Warszawa, Torfarm, Urtica, Medyk-Lekpan, Polska Grupa Farmaceutyczna, Pharmalink, Centrala Farmaceutyczna CEFARM and Hurtap S.A., and anyone reading that list for the first time should know that it describes the Poland stationary pharmacy distribution and wholesale market through sixteen entries that are not sixteen independent competitors.
Several entries overlap. PGF Polska Grupa Farmaceutyczna and Polska Grupa Farmaceutyczna are the abbreviation and the full name of the same business, listed twice. Centrala Farmaceutyczna CEFARM and Cefarm Warszawa both carry the CEFARM name. Urtica, Pharmalink and PGF are publicly described as operating lines of Pelion S.A., and Cefarm Warszawa is publicly described as a company of the Farmacol group.
The list is therefore best read as a set of groups, their operating lines and a number of other wholesale businesses, rather than as a count of separate rivals. A buyer who treats each name as an independent alternative may overestimate the amount of real choice available, because some names are brands, divisions or subsidiaries of one group.
Grupa Olmed is the first-named company in the list used for this report, and the full report covers it in the company profiles. The same factual standard applies to every company named here, and no company is described as better or larger than another.
This page therefore organises the landscape by business type: national full-line groups, regional and cooperative-style wholesalers, and specialised and therapeutic distributors. It does not give rankings, shares, financial figures or capability claims, which are reserved for the full report.
A second reason for care is that names persist after ownership changes. A wholesaler acquired by a group often keeps its brand, its warehouse and its customer relationships, so the visible name stays on the invoice while the owner behind it changes. Readers who match a name on a delivery note with a name on a list may therefore be looking at the same group from two directions.
Reading the landscape by type has a practical advantage. A pharmacy or a manufacturer choosing a distribution partner is choosing between ways of serving customers, such as breadth, local presence or specialisation, before it is choosing between named companies.
National Full-Line Groups
National full-line groups carry a broad assortment, deliver to pharmacies across most of the country and operate several warehouses with frequent delivery rounds. In the company list, NEUCA Group, Pelion S.A. and Farmacol S.A. are the names most often presented in this way in public materials.
NEUCA Group is a publicly listed group whose wholesale distribution to pharmacies sits alongside partnership programmes in which pharmacies take part, and it has publicly emphasised its relationship with independent pharmacies. Pelion S.A. is a publicly listed group that is publicly described as operating PGF Polska Grupa Farmaceutyczna, Urtica and Pharmalink as lines within its structure.
Farmacol S.A. is a pharmaceutical wholesale group that is publicly described as including Cefarm Warszawa among its companies. In each case, the useful point for a reader is the structure: a national group typically runs a core wholesale business and surrounds it with additional lines for particular customers, products or services.
What a national group can offer is scale in the three things pharmacies value most: assortment breadth, delivery frequency and service platforms. What it gives up, at least in principle, is the personal and local flexibility of a smaller operator, although many groups try to preserve this through regional teams and partnership programmes.
National groups also have the capacity to invest in cold-chain facilities, automation and digital ordering. Those capabilities are expensive and are spread over a large customer base, which is why they tend to appear first in the largest groups and later, if at all, in smaller ones.
Service platforms are the part of the offer that has changed most. Ordering systems, pharmacy partnership programmes, training, marketing support and range advice now sit alongside the physical delivery, and they are what a national group typically emphasises when it describes its relationship with independent pharmacies and chains.
None of this establishes that any group is better for a particular buyer. A pharmacy with a long-standing relationship with a local wholesaler may judge service more important than breadth, and a chain may favour whichever group integrates best with its own systems.
Regional and Cooperative-Style Wholesalers
Regional wholesalers serve a defined area and compete mainly on local presence, relationships and flexibility. Cooperative-style businesses are owned or closely supported by the pharmacies they serve, and they exist to give those pharmacies supply terms and services that a single outlet could not obtain on its own.
Among the remaining listed businesses, ACP Pharma, Salus International, Prosper S.A., Torfarm, Medyk-Lekpan, Centrala Farmaceutyczna CEFARM and Hurtap S.A. are wholesale businesses serving the pharmacy channel, and the full report profiles the geographic footprint, customer focus and recent developments of each one. This page does not characterise their individual operations beyond that.
Whether a particular business takes a regional or cooperative form is a question of its ownership and customers, and the distribution models these groups operate range from regional agreements to franchise and partnership networks.
The strength of smaller wholesalers is that they can respond quickly to a local pharmacy, accept less standard requests and keep decision-making close to the customer. The limits are a narrower range, less capacity for investment and greater exposure to a small number of large customers or suppliers.
Many smaller wholesalers address the range problem through buying alliances and by acting as a second source for pharmacies that rely mainly on a national group. This arrangement is common, because pharmacies value having an alternative when a first-choice supplier runs out of a product.
Local knowledge is the quieter strength of this type. A regional wholesaler often knows which pharmacies lose stock on Monday mornings, which routes are slow in winter and which towns have a single pharmacy that cannot afford to run out, and it plans its rounds around that knowledge rather than around a national schedule.
Consolidation is a recurring theme at this end of the sector. Smaller wholesalers can be acquired by larger groups, merge with each other or join networks, and each such change alters the overlaps described earlier in this page.
|
COMPETITIVE WATCH
|
Specialised and Therapeutic Distributors
Specialised and therapeutic distributors concentrate on particular products, therapeutic areas or customer types, such as hospitals, rather than on a full assortment for community pharmacies. Their value is in handling expertise, manufacturer relationships and responsiveness to complex orders.
Urtica and Pharmalink are publicly described as operating within the Pelion group, which illustrates a pattern worth understanding: a national group may use separate commercial lines to serve different customers or product areas, so that specialisation can exist inside a large group as well as outside it.
Independent specialised distributors, by contrast, may be appointed by manufacturers for products that need controlled distribution, and they often hold narrower but deeper positions with hospitals, specialised pharmacies and prescribers. Their quality systems matter more to customers than their delivery frequency.
For manufacturers, specialised distributors offer focus. A company launching a high-value or temperature-sensitive product may prefer a partner that gives it close attention over one that treats it as one line among thousands, and for hospitals they offer reliable supply of products that are difficult to source otherwise.
Hospitals and institutions are the natural customers of this type. They place larger, less frequent orders against a defined list, they value documentation and responsiveness, and they are often prepared to work with a distributor that is smaller than a national group if it handles a difficult product reliably.
The boundary between a specialised distributor and a full-line wholesaler is not fixed. Full-line groups are building specialty and cold-chain capability, and specialists are adding general products to broaden their customer relationships, so the two types increasingly overlap.
How Company Type Relates to Buyer Need
Different buyers need different things from a distributor, and the customers each company type serves tend to line up with the strengths of each type described above.
An independent pharmacy that wants dependable breadth and a personal relationship may be best served by a national group with strong regional teams, or by a regional wholesaler that knows its local market. A rural pharmacy may value route coverage above all, while an urban high-volume pharmacy may value delivery frequency and digital ordering.
A pharmacy chain tends to favour partners that can integrate with central systems, deliver consistently across a wide network and support its own procurement team with data. These requirements point toward national groups, although chains often add regional or specialised distributors to secure alternatives.
Hospitals and other institutions buy through formal procurement and look for distributors with tender capability, documentation support and the ability to hold a defined list across a contract period. Both institutional suppliers inside national groups and independent specialists compete for this business.
Timing is a further difference. A pharmacy may need a delivery within hours, a chain may need predictable weekly rounds, and a hospital may need a delivery on a fixed day each month. A distributor that is excellent at one rhythm is not automatically strong at another, which is why company type, rather than company name, is the more reliable guide.
Manufacturers have their own needs, which include reach, reliable handling of their products, accurate sales data and a counterpart with the capacity to carry launches. A manufacturer will often use more than one type of distributor, matching each product to the partner whose strengths fit it.
The overall point is that the landscape rewards fit rather than size alone. The full report provides profiles of all sixteen listings, including ownership, geographic footprint, portfolio, target customers, distribution approach, certifications and recent developments, which allow readers to judge fit for themselves.
Frequently Asked Questions
The report covers sixteen listings: Grupa Olmed, NEUCA Group, Pelion S.A., Farmacol S.A., PGF Polska Grupa Farmaceutyczna, ACP Pharma, Salus International, Prosper S.A., Cefarm Warszawa, Torfarm, Urtica, Medyk-Lekpan, Polska Grupa Farmaceutyczna, Pharmalink, Centrala Farmaceutyczna CEFARM and Hurtap S.A.
Not always. PGF Polska Grupa Farmaceutyczna and Polska Grupa Farmaceutyczna are one business listed twice, and Urtica, Pharmalink and PGF are publicly described as operating lines of Pelion S.A. Cefarm Warszawa is publicly described as a Farmacol group company.
It is a distributor that concentrates on particular products, therapeutic areas or customer types rather than a full assortment, offering handling expertise and close manufacturer relationships.
It is a group that carries a broad assortment, delivers to pharmacies across most of the country and runs frequent delivery rounds, often with additional operating lines around the core wholesale business.
By fit with its own needs: assortment breadth, delivery frequency, local presence, digital ordering and service support, rather than by company size alone.